Status:
COMPLETED
Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).
Lead Sponsor:
Erasmus Medical Center
Collaborating Sponsors:
Reinier de Graaf Groep
Albert Schweitzer Hospital
Conditions:
Inflammatory Bowel Disease (IBD)
Ulcerative Colitis
Eligibility:
All Genders
10-20 years
Phase:
NA
Brief Summary
The presented study aims to reduce symptoms of depression and anxiety in adolescents with inflammatory bowel disease and increased symptoms of anxiety and depression by using the disease specific CBT ...
Detailed Description
1. Objective: The primary objective is to determine the efficacy of a disease specific cognitive behavioral therapy program in adolescents with IBD and increased symptoms of depression or anxiety on r...
Eligibility Criteria
Inclusion
- Patients between 10-25 years with diagnosed IBD
- Informed consent or assent by patients and (if necessary) parents
Exclusion
- IBD patients with parental report of mental retardation
- IBD patients receiving psychopharmacological treatment (antidepressants or benzodiazepines) for depression or anxiety
- No mastery of the Dutch language
- IBD patients with diagnosed: Bipolar disorder, Schizophrenia/psychotic disorder, Autism spectrum disorders, Obsessive-compulsive disorder, Posttraumatic stress disorder/Acute stress disorder, or Substance use disorder
- Physician reported substance abuse (alcohol, drugs) in the past month
- Clinician reported Selective mutism
- IBD patients already participating in an (psychological of psychopharmacological) intervention study
- IBD patients who received 8 sessions of manualized cognitive behavioral therapy last year
- current psychological treatment
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 24 2017
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT02265588
Start Date
September 1 2014
End Date
August 24 2017
Last Update
July 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus Medical Center
Rotterdam, Nederland, Netherlands, 3015CN